NEU1 and systemic lupus erythematosus: Cellular experiments discovered that in patients with active SLE, activated T cells exhibit reduced binding to Galectin-1 (Gal-1), and there is an increased gene expression rate of sialyltransferase and sialidase-1 (NEU1) [44].